NEW DELHI, February 5, 2018 /PRNewswire/ --
Pluss® Advanced Technologies, winner of the National Technology Day Innovation Award for its patent pending device MiraCradle® to treat Birth Asphyxia, announces the signing of a collaboration agreement with Dräger, an international leader in the fields of medical and safety technology.
Birth asphyxia, or lack of oxygen at birth, is one of the leading causes of infant mortality in low and middle income countries. The World Health Organization estimates that over 650,000 babies worldwide die from birth asphyxia each year. Those who survive the condition often suffer serious and irreparable damage that can result in lifelong physical and mental disabilities.
Developed in collaboration with CMC Vellore, MiraCradle® - Neonate Cooler is the world's first affordable, non-electronic, portable device based on savE® Phase Change Materials (PCMs) which helps in cooling the baby and maintains the core body temperature precisely between 33-34?C for a period of 72 hours.
"Technology for a better world has been the motto at Pluss®. That we could help overcome such a huge disease burden sowed the seed of development of MiraCradle®", says Samit Jain, Managing Director at Pluss®.
"With over 200 installations and thousands of babies now successfully treated on MiraCradle® in India, it's time to share this standard of care practice globally", added Udit Mangal, Business Manager at Pluss®. "In this endeavor, Pluss® and Dräger are joining hands to leverage upon each other's strengths and to help bring this to as many lower and middle income group countries as possible. The immediate focus is to be able to make this available in the countries of Asia and Africa and later also South America."
About Pluss® Advanced Technologies
A pioneer in advanced Phase Change Material(PCM)technology, Pluss® is the only Indian company engaged in research and indigenous development of PCMs for a wide range temperature requirement with several patents. For Pluss®, the focus is on creating value for them by designing innovative products and solutions in the field of Speciality Polymers and Phase Change Materials. Pluss® PCMs are used in the diversified fields of healthcare, pharma, food, logistics, construction, etc. for providing solutions for energy efficient and reliable temperature control. In Nov 2012, the company had an equity infusion from Tata Capital Innovations Fund which enabled Pluss® develop new products and enter international markets. Pluss® believes in consistent and pragmatic innovations. With its innovation streak, Pluss® is making its presence felt across the globe in USA, Turkey, South East Asia, Russia, Ukraine and South Africa. Please visit http://www.pluss.co.in/ for more information.
Advertisement
Pluss® Advanced Technologies, winner of the National Technology Day Innovation Award for its patent pending device MiraCradle® to treat Birth Asphyxia, announces the signing of a collaboration agreement with Dräger, an international leader in the fields of medical and safety technology.
Advertisement
Birth asphyxia, or lack of oxygen at birth, is one of the leading causes of infant mortality in low and middle income countries. The World Health Organization estimates that over 650,000 babies worldwide die from birth asphyxia each year. Those who survive the condition often suffer serious and irreparable damage that can result in lifelong physical and mental disabilities.
Developed in collaboration with CMC Vellore, MiraCradle® - Neonate Cooler is the world's first affordable, non-electronic, portable device based on savE® Phase Change Materials (PCMs) which helps in cooling the baby and maintains the core body temperature precisely between 33-34?C for a period of 72 hours.
"Technology for a better world has been the motto at Pluss®. That we could help overcome such a huge disease burden sowed the seed of development of MiraCradle®", says Samit Jain, Managing Director at Pluss®.
"With over 200 installations and thousands of babies now successfully treated on MiraCradle® in India, it's time to share this standard of care practice globally", added Udit Mangal, Business Manager at Pluss®. "In this endeavor, Pluss® and Dräger are joining hands to leverage upon each other's strengths and to help bring this to as many lower and middle income group countries as possible. The immediate focus is to be able to make this available in the countries of Asia and Africa and later also South America."
About Pluss® Advanced Technologies
A pioneer in advanced Phase Change Material(PCM)technology, Pluss® is the only Indian company engaged in research and indigenous development of PCMs for a wide range temperature requirement with several patents. For Pluss®, the focus is on creating value for them by designing innovative products and solutions in the field of Speciality Polymers and Phase Change Materials. Pluss® PCMs are used in the diversified fields of healthcare, pharma, food, logistics, construction, etc. for providing solutions for energy efficient and reliable temperature control. In Nov 2012, the company had an equity infusion from Tata Capital Innovations Fund which enabled Pluss® develop new products and enter international markets. Pluss® believes in consistent and pragmatic innovations. With its innovation streak, Pluss® is making its presence felt across the globe in USA, Turkey, South East Asia, Russia, Ukraine and South Africa. Please visit http://www.pluss.co.in/ for more information.
Dräger Technology for Life®
Dräger is an international leader in the fields of medical and safety technology. Our products protect, support and save lives. Founded in 1889, Dräger generated revenues of around EUR 2.5 billion in 2016. The Dräger Group is currently present in more than 190 countries and has more than 13,000 employees worldwide.
Please visit http://www.draeger.com for more information.
Media Contact:
Udit Mangal
[email protected]
+(91)9599447670
Business Manager- Healthcare
Pluss Advanced Technologies
